Science and Technology

Lecanemab drug for Alzheimer

January 15 , 2023 553 days 391 0

The US Food and Drug Administration has approved lecanemab (Leqembi) for treatment of Alzheimer’s disease.
Lecanemab, which will be sold under the brand name Leqembi, is the first Alzheimer’s treatment of its kind.

Post Views:
391

TNPSC Group 1 2020 Prelims Free Mock Test State Level

PREVIOUS

Filter Micro-plastics from Water

NEXT

New electrolyte to Ammonia synthesis

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Please enter captcha below:

TNPSC Group 1 2020 Prelims Free Mock Test State Level

Categories